ACE and ovarian neoplasm: SCID mice were protected against inoculation with HER-2/neu+, HLA-A2.1+ human tumour cell lines when bulk CTL specific for ACE prepared from the HER-2/neu-overexpressing primary ovarian tumours were adoptively transferred.